Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?

To: Goose94 who wrote (96321)	10/21/2020 9:46:29 AM
From: Goose94	Read Replies (1) \| Respond to of 202702

CloudMD Software & Services (DOC-V) new 52 week high, $3.23

To: Goose94 who wrote (96321)	6/23/2021 2:02:23 PM
From: Goose94	Read Replies (1) \| Respond to of 202702

CloudMD Software & Services (DOC-V) top pick from Stephen Takacsy on BNN.ca Market Call Wed June 23rd @ 1200ET One of the fastest growing technology healthcare solutions providers to clinics, enterprises and patients. They are making a big push into EHS (Enterprise Health Solutions) by offering a centralized “whole patient” platform integrating primary care, mental health, eye and other specialty care for employers and insurance companies into a holistic “one stop shop” approach. This should help make it easier and quicker to deal with employee health issues and reduce absenteeism, which is a big problem. They made a flurry of acquisitions, which they are in the process of integrating. Pro-forma annualized revenue run-rate is expected to be around $120M with EBITDA between $5M and $10M. The stock has been weak as the market is waiting for two large acquisitions to close: Oncidium and VisionPros. This provides a great opportunity to invest in the sector at a reasonable price of under 3X revenues versus peers like Well Health and Dialogue trading at significantly higher multiples.